Pharmacist Chronic Kidney Disease | Diabetes | Patient Safety | Weight Management Live 1 credit hour Annual Update
LIVE WEBINAR: March 3, 2026 7:00 PM - 8:00 PM (Central Time)

Diabetes guidelines continue to shape clinical practice by refining approaches to screening, diagnosis, therapy selection, technology use, and the management of related health conditions. This course discusses the latest updates and highlights how these recommendations influence comprehensive diabetes care. You will learn how guideline changes can inform person-centered management strategies, support safe and effective medication use, and enhance your role in optimizing outcomes for people living with diabetes across practice settings.

Learning Objectives

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Describe updates within the latest ADA diabetes guidelines that influence clinical assessment and therapeutic decision-making.
2. Identify revised recommendations related to screening, monitoring, and risk reduction in diabetes care.
3. Discuss changes in pharmacologic guidance, including considerations for safety, efficacy, and comorbidity management.
4. Explain updated recommendations regarding the use of diabetes-related technologies and their role in supporting treatment goals.
5. Develop an individualized care approach that incorporates updated diabetes guideline recommendations into pharmacy practice.

Faculty

Susan Cornell, PharmD, CDCES, FAPhA, FADCES

Professor, Pharmacy Practice,
Diabetes Care & Education Specialist
Midwestern University College of Pharmacy 

Disclosures:

Susan Cornell is an advisory board member for Noro Nordisk. All relevant financial relationships have been mitigated.

Course Details